Protein digestibility of aquafeeds in Sparus aurata: A model for in vitro bioaccessibility validation in fish.

Food Res Int

MARE - Marine and Environmental Sciences Centre & ARNET, Aquatic Research Infrastructure Network Associate Laboratory, Faculdade de Ciências da Universidade de Lisboa (FCUL), Campo Grande, 1749-016 Lisboa, Portugal; IPMA, I.P. - Portuguese Institute for the Sea and Atmosphere, I.P., Division of Aqu

Published: August 2025


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

The in vitro assessment of nutrient digestibility in aquaculture offers a fast, affordable, and ethical alternative enabling to optimize the nutritional value of feeds for improved fish health. Although commonly used in human studies, these in vitro models are still scarce for fish. This study aimed to validate an in vitro digestion method for marine fish using both fish crude digestive extracts and commercial digestive enzymes through a comparison with an in vivo assay using gilthead seabream (Sparus aurata) as a biological model. Additionally, the effects of temperature, digestion time and feed amount (enzyme-to-substrate [E:S] ratio) influenced the in vitro protein digestibility, either individually or through their interactions. Only commercial enzymes lead to similar protein bioaccessibilities to those obtained in vivo (90.8 ± 1.7 %) under the following factorial design: i) 20 °C, 24 h, 250 mg of feed (88.1 ± 2.6 %); ii) 37 °C, 6 h, 136.5, 250 and 500 mg (85.9 ± 2.5 %, 90.1 ± 3.0 % and 87.4 ± 1.0 %, respectively); and iii) 37 °C, 24 h, 500 and 1000 mg (86.0 ± 2.1 %, 86.6 ± 5.2 %, respectively). The distinct action mechanisms of non-fish commercial enzymes seem to significantly enhance protein bioaccessibility compared to fish digestive extracts. Moreover, an optimal balance between temperature and digestion time plays a crucial role in maximizing digestibility, supporting efficient nutrient breakdown and absorption. The validated in vitro digestibility method using commercial enzymes for S. aurata provides a cost-effective, fast alternative and free of ethical constraints. We also propose a standardized E:S ratio to be applied in future studies using this methodology.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.foodres.2025.116554DOI Listing

Publication Analysis

Top Keywords

commercial enzymes
12
protein digestibility
8
sparus aurata
8
digestive extracts
8
temperature digestion
8
digestion time
8
vitro
6
fish
6
protein
4
digestibility aquafeeds
4

Similar Publications

The mutagenic translesion synthesis (TLS) pathway, which is critically dependent on REV1's ability to recruit inserter TLS polymerases and the POLζ extender polymerase, enables cancer cells to bypass DNA lesions while introducing mutations that likely contribute to the development of chemotherapy resistance and secondary malignancies. Targeting this pathway represents a promising therapeutic strategy. Here, we demonstrate that the expression of the C-terminal domain (CTD) of human REV1, a ca.

View Article and Find Full Text PDF

Introduction: Trastuzumab deruxtecan (T-DXd) has revolutionised treatment for metastatic breast cancer (MBC). While effective, its high cost and toxicities, such as fatigue and nausea, pose challenges.

Method: Medical records from the Joint Breast Cancer Registry in Singapore were used to study MBC patients treated with T-DXd (February 2021-June 2024).

View Article and Find Full Text PDF

Retinol binding protein 4 (RBP4), the circulating carrier of retinol, complexes with transthyretin (TTR) and is a potential biomarker of cardiometabolic disease. However, RBP4 quantitation relies on immunoassays and Western blots without retinol and TTR measurement. A liquid chromatography-tandem mass spectrometry (LC-MS/MS) method for the simultaneous absolute quantitation of circulating RBP4 and TTR is critical to establishing their biomarker potential.

View Article and Find Full Text PDF

Multilayered Sandwich Structure Sensor: Confinement-Mediated HO Enrichment Strategy for Ultrasensitive and Long-term Stable Prostate Cancer Biomarker Detection.

Small

September 2025

School of Chemistry and Chemical Engineering, Guangxi Key Laboratory of AI-Driven Zero-Carbon Technologies, Key Laboratory of New Low-carbon Green Chemical Technology Education Department of Guangxi Zhuang Autonomous Region, Guangxi University, Nanning, 530004, China.

Sarcosine (Sar), a critical potential biomarker for prostate cancer (PCa), is primarily detected via enzyme cascade reactions involving sarcosine oxidase (SOx) and peroxidase. Nevertheless, the intermediate product hydrogen peroxide (HO) tends to diffuse to the bulk solution phase without entering subsequent reaction, leading to suboptimal detection sensitivity and compromised analytical performance. To tackle this challenge, a multilayered sandwich nanozyme cascade sensor (designated as Cu-MOF/Rf@BDC) is proposed through a confinement-mediated HO enrichment strategy.

View Article and Find Full Text PDF

A myotropic AAV vector combined with skeletal muscle -regulatory elements improve glycogen clearance in mouse models of Pompe disease.

Mol Ther Methods Clin Dev

June 2025

Université Paris-Saclay, University Evry, Inserm, Genethon, Integrare Research Unit UMR_S951, 91000 Evry, France.

Pompe disease is a glycogen storage disorder caused by mutations in the acid α-glucosidase (GAA) gene, leading to reduced GAA activity and glycogen accumulation in heart and skeletal muscles. Enzyme replacement therapy with recombinant GAA, the standard of care for Pompe disease, is limited by poor skeletal muscle distribution and immune responses after repeated administrations. The expression of GAA in muscle with adeno-associated virus (AAV) vectors has shown limitations, mainly the low targeting efficiency and immune responses to the transgene.

View Article and Find Full Text PDF